Endocyte Inc.'s decision two years ago to shelve its own pipeline and look for other opportunities was a difficult call that eventually paid off for investors, its former CEO said Friday at IBJ’s Life Sciences Power Breakfast.
Purdue University’s growing success at moving ideas into the marketplace has earned it high regard in a report released Thursday by an economic think tank.
Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.
Purdue University Professor You-Yeon Won’s development, called radio-luminescent nanoparticles, is designed to enhance the cancer-cell-killing effects of radiation treatment.
A professor in the Indiana School of Medicine is hopeful that an antibiotic cocktail he invented will one day improve the lives of millions of people, thanks in part to the Indiana University Research and Technology Corp., formed in 1997 to make work done by IU faculty and researchers available for commercial development.
Finding and supporting savvy people might result in more life sciences startups.
The envisioned 26-acre, $200-million-or-more complex would bridge IU’s School of Medicine with the city’s life sciences firms, including those at the nascent 16 Tech, a business park.
The U.S. Senate this week confirmed President Barack Obama's nomination of France Cordova to lead the federal agency that has a $7 billion budget to award grants for scientific research around the country.
Indiana’s life sciences sector is mostly composed of legacy companies.
Companies looking to license and crunch massive amounts of data as part of their product development are turning to Purdue University for help.
Monday's Supreme Court decision is a victory for companies that collaborate with universities in research. Indianapolis-based Eli Lilly and Co. was among the companies that supported Roche.
A complicated legal case about trade secrets points up a down side to the success Indiana’s research universities have had turning their research into revenue: Large legal bills can eat much of the money.
Mark Long was president of the Indiana University Research & Technology Corp., which was responsible for the university’s tech transfer, before launching a consulting firm, Long Performance Advisors, in 2008.
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
The Indiana Clinical and Translational Sciences Institute awarded $750,000 to 10 teams of researchers.